Contact Person
    Helen Pettersson

    Senior Project Manager
    Phone: (M) +45 2337 0040

    Academic Drug Discovery

    Welcome to Academic Drug Discovery – how to secure that preclinical findings reach the patients

    The Medicon Valley universities have many research activities within early drug discovery and they offer a wide range of know-how and research within new therapeutic goals and new and innovative methods to develop drugs. These activities can support drug development not only at the universities but also at other life-science institutions/companies in the region. However, there is currently no clear formalized initiative between academic preclinical drug discovery, clinical trials and the region’s life science industry. How can we ensure maximum exchange between preclinical research findings, related knowledge, and technologies from the academia and the life-science industry and thereby facilitate the progression of novel drug candidates so that they reach all the way to patients and create social benefits?

    University of Copenhagen, Lund University, and Medicon Valley Alliance invite you to Academic Drug Discovery – how to secure that preclinical findings reach the patients:

    Date: 23 August 2018
    Time: 8.30 – 16.30
    Venue: Nielsine Nielsen auditorium, The Maersk Tower, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N
    Cost: Free of charge for MVA members

    Sign up – This event is fully booked. Please sign up to be included on our waiting list

    By strengthening preclinical drug discovery, increasing the number of academic clinical studies, and optimizing trial designs by e.g. including companion diagnostics, important prerequisites to ensure continued growth of the Swedish-Danish life science sector are created. This event intends to serve as a first step in establishing a more effective regional platform for academic/clinical drug research.



    Registration and networking


    Welcome and introduction
    Petter Hartman, CEO, Medicon Valley Alliance
    Trine Winterø, Vice-Dean for Innovation and External Relations, University of Copenhagen
    Nils Brünner, Professor emeritus & CEO, Scandion Oncology
    Roland Andersson, Professor, Lund University


    NEXT – a public – private partnership to attract clinical trials to Denmark – how do we
    do and what is needed to ensure attractiveness?
    Britta Smedegaard, Project Director, NEXT


    The patent perspective – Dos and Don’ts
    Jens Viktor Nørgaard, Partner & European Patent Attorney, HØIBERG P/S


    The enzyme MTH1 as a novel target in cancer therapy – a journey from the lab bench to first-in-human clinical trial
    Ulrika Warpman Berglund, PhD, Project Manager, Karolinska Institutet, SciLifeLab


    Fish and  Grasshoppers in the Service of MANkind
    Roger Olsson, Professor of  Chemical Biology, Lund University


    Coffee and networking


    From academic discoverers to biotech
    Kristian Strømgaard, Professor, University of Copenhagen


    Drug discovery in Immuno-Oncology
    Peter Ellmark, Vice President Discovery, Alligator Bioscience AB


    From brain research to applied science – How do we transform great academic ideas into drugs
    Anders Gersel Pedersen, Executive Vice President, H. Lundbeck A/S


    BioInnovation Institute: Helping life science entrepreneurs to bring science out of the
    lab and into the economy
    Thomas Nagy, Director, BioInnovation Institute


    Lunch & networking


    Workshop: How to create a formalized platform for academic drug discovery including infrastructure and know-how
    All attendees


    Summary of workshop and next step
    Nils Brünner, Professor emeritus & CEO, Scandion Oncology


    Panel discussion


    Refreshments and networking

    Deadline for registration is 17th of August, 2018.

    For more information please contact Senior Project Manager Helen Pettersson:

    In collaboration

    logo uni_copenhagen  logo LU

    mva logo